Blue Water Life Science Advisors

Latest statistics and disclosures from Blue Water Life Science Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NTRA, GH, AKYA, CDNA, TXG, and represent 91.76% of Blue Water Life Science Advisors's stock portfolio.
  • Added to shares of these 2 stocks: CDNA (+$7.9M), TXG.
  • Started 1 new stock position in CDNA.
  • Reduced shares in these 2 stocks: ADPT (-$5.4M), QTRX.
  • Sold out of its position in ADPT.
  • Blue Water Life Science Advisors was a net buyer of stock by $2.8M.
  • Blue Water Life Science Advisors has $103M in assets under management (AUM), dropping by -3.28%.
  • Central Index Key (CIK): 0001789778

Tip: Access up to 7 years of quarterly data

Positions held by Blue Water Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Blue Water Life Science Advisors

Blue Water Life Science Advisors holds 8 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Natera (NTRA) 53.0 $55M 503k 108.29
 View chart
Guardant Health (GH) 16.0 $17M 571k 28.88
 View chart
Akoya Biosciences (AKYA) 10.7 $11M 4.7M 2.34
 View chart
Caredx (CDNA) 7.7 $7.9M NEW 510k 15.53
 View chart
10x Genomics Cl A Com (TXG) 4.4 $4.5M +18% 230k 19.45
 View chart
Quanterix Ord (QTRX) 3.6 $3.7M -9% 278k 13.21
 View chart
EXACT Sciences Corporation (EXAS) 2.4 $2.4M 57k 42.25
 View chart
Maxcyte (MXCT) 2.3 $2.4M 604k 3.92
 View chart

Past Filings by Blue Water Life Science Advisors

SEC 13F filings are viewable for Blue Water Life Science Advisors going back to 2020